Current Report Filing (8-k)
May 17 2022 - 10:16AM
Edgar (US Regulatory)
0001497130
false
0001497130
2022-01-18
2022-01-18
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
Current
Report
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
January 18, 2022
NANO
MOBILE HEALTHCARE, INC.
(Exact
Name of Registrant as Specified in its Charter)
Nevada (State
or other jurisdiction of incorporation) |
000-55155 (Commission File
Number) |
98-0659770 (I.R.S.
Employer Identification No.) |
370
Amapola Avenue Suite 200-A
Torrance, CA 90501
(Address of Principal Executive Offices and Zip Code)
Registrant’s
telephone number, including area code: (424) 358-1046
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
☐ |
Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425) |
☐ |
Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12) |
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company [X]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
Trading
Symbol(s) |
Name
of each exchange on which registered |
Common
Stock, par value of $0.00001 |
VNTH |
OTCMKTS |
SECTION
5 – CORPORATE GOVERNANCE AND MANAGEMENT
Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of
Certain Officers.
On
January 18, 2022, the Company appointed Mr. Frank I Igwealor as its President and CEO,
effectively immediately. The Company believes that Mr. Igwealor’s vast experience would help to find a suitable merger for
the Company to capitalize on emerging opportunities in the Web3, Gaming, Crypto and Metaverse industries. The Company also believes that
bringing Mr. Igwealor back to actively manage the Company will provide it with the vision and grit to achieve its objectives.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
NANO
MOBILE HEALTHCARE, INC.
Date: May 16, 2022 |
By:
/s/ Frank I Igwealor |
|
Name: |
Frank I Igwealor,
JD, MBA, CPA, CMA, CFM, MSRM, ESQ. |
|
Title: |
Interim Chairman |
Nano Mobile Healthcare (PK) (USOTC:VNTH)
Historical Stock Chart
From Aug 2024 to Sep 2024
Nano Mobile Healthcare (PK) (USOTC:VNTH)
Historical Stock Chart
From Sep 2023 to Sep 2024